Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better? Comment

被引：1
|
作者：
Guven, D. C. [1 ]
Taban, H. [1 ]
Dizdar, O. [1 ]
机构：
[1] Hacettepe Univ, Canc Inst, Dept Med Oncol, Ankara, Turkey
来源：
JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2022年 / 28卷 / 01期
关键词：
adjuvant; capecitabine; triple negative breast cancer; PHASE-III TRIAL; COMBINATION; DOCETAXEL;
D O I：
10.1177/10781552211045909
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：203 / 204
页数：2
相关论文
共 50 条
  • [21] Addition of Capecitabine to Adjuvant Chemotherapy May be the Most Effective Strategy for Patients With Early-Stage Triple-Negative Breast Cancer: A Network Meta-Analysis of 9 Randomized Controlled Trials
    Li, Zhiyang
    Zheng, Jiehua
    Ji, Zeqi
    Chen, Lingzhi
    Wu, Jinyao
    Zou, Juan
    Liu, Yiyuan
    Lin, Weixun
    Cai, Jiehui
    Chen, Yaokun
    Chen, Yexi
    Lu, Hai
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study
    Tasci, Elif Senocak
    Kutlu, Yasin
    Olmez, Omer Fatih
    Mutlu, Arda Ulas
    Gundogdu, Yasemin
    Seyyar, Mustafa
    Sahin, Elif
    Cabuk, Devrim
    Majidova, Nargiz
    Ugurlu, Irem
    Demirci, Ayse
    Aydin, Dincer
    Cavdar, Eyup
    Bayram, Selami
    Yildirim, Nilgun
    Karatas, Fatih
    Eryilmaz, Melek Karakurt
    Caglayan, Dilek
    Menekse, Serkan
    Kut, Engin
    Arak, Haci
    Keser, Murat
    Sunar, Veli
    Perkin, Perihan
    Sakalar, Teoman
    Oyan, Basak
    Sonmez, Ozlem
    Ozer, Leyla
    Yildiz, Ibrahim
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (04) : 477 - 484
  • [23] Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis
    Yan Li
    Yidong Zhou
    Feng Mao
    Yan Lin
    Xiaohui Zhang
    Songjie Shen
    Qiang Sun
    Breast Cancer Research and Treatment, 2020, 179 : 533 - 542
  • [24] Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
    de Boo, Leonora W.
    Jozwiak, Katarzyna
    Joensuu, Heikki
    Lindman, Henrik
    Lauttia, Susanna
    Opdam, Mark
    van Steenis, Charlaine
    Brugman, Wim
    Kluin, Roelof J. C.
    Schouten, Philip C.
    Kok, Marleen
    Nederlof, Petra M.
    Hauptmann, Michael
    Linn, Sabine C.
    BRITISH JOURNAL OF CANCER, 2022, 126 (10) : 1401 - 1409
  • [25] The advance of adjuvant treatment for triple-negative breast cancer
    Ge, Jingyu
    Zuo, Wenjia
    Chen, Yiyu
    Shao, Zhiming
    Yu, Keda
    CANCER BIOLOGY & MEDICINE, 2022, 19 (02) : 187 - 201
  • [26] Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer
    Locatelli, Marzia A.
    Curigliano, Giuseppe
    Eniu, Alexandru
    BREAST CARE, 2017, 12 (03) : 152 - 158
  • [27] Patients with triple negative breast cancer: Is there an optimal adjuvant treatment?
    Burstein, Harold J.
    BREAST, 2013, 22 : S147 - S148
  • [28] Triple negative breast cancer: adjuvant chemotherapy effect on survival
    Steponaviciene, L.
    Lachej-Mikeroviene, N.
    Smailyte, G.
    Aleknavicius, E.
    Meskauskas, R.
    Didziapetriene, J.
    ADVANCES IN MEDICAL SCIENCES, 2011, 56 (02): : 285 - 290
  • [29] Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
    Masuda, N.
    Lee, S. -J.
    Ohtani, S.
    Im, Y. -H.
    Lee, E. -S.
    Yokota, I.
    Kuroi, K.
    Im, S. -A.
    Park, B. -W.
    Kim, S. -B.
    Yanagita, Y.
    Ohno, S.
    Takao, S.
    Aogi, K.
    Iwata, H.
    Jeong, J.
    Kim, A.
    Park, K. -H.
    Sasano, H.
    Ohashi, Y.
    Toi, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (22) : 2147 - 2159
  • [30] Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial
    Asleh, Karama
    Brauer, Heather Ann
    Sullivan, Amy
    Lauttia, Susanna
    Lindman, Henrik
    Nielsen, Torsten O.
    Joensuu, Heikki
    Thompson, E. Aubrey
    Chumsri, Saranya
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 2603 - 2614
12345